%0 Journal Article
%T Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease
%A Csaba P. Kovesdy
%A Donovan A. Argueta
%A Hamid Moradi
%A Janice T. Chua
%A Kamyar Kalantar-Zadeh
%A Nicholas V. DiPatrizio
%A Nosratola D. Vaziri
%J Archive of "Cannabis and Cannabinoid Research".
%D 2019
%R 10.1089/can.2018.0060
%X Introduction: As the prevalence of kidney disease continues to rise worldwide, there is accumulating evidence that kidney injury and dysfunction, whether acute or chronic, is associated with major adverse outcomes, including mortality. Meanwhile, effective therapeutic options in the treatment of acute kidney injury (AKI) and chronic kidney disease (CKD) have been sparse. Many of the effective treatments that are routinely utilized for different pathologies in patients without kidney disease have failed to demonstrate efficacy in those with renal dysfunction. Hence, there is an urgent need for discovery of novel pathways that can be targeted for innovative and effective clinical therapies in renal disease states
%K acute kidney injury
%K chronic kidney disease
%K endocannabinoid
%K fibrosis
%K inflammation
%K nephropathy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653784/